Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 11:29:41 2024-04-26 am EDT			5-day change	1st Jan Change
3.295 ^SEK	+64.91%		+59.56%	-10.95%

Mar. 13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI
Feb. 27	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q-linea AB Signs Distribution Partnership for ASTar Instrument and Consables for France with Eurobio Scientific

June 13, 2023 at 07:05 am EDT

Q-linea AB (publ) announced that the company has signed a distribution partnership for ASTar® Instrument and consumables for France with Eurobio Scientific. In line with Q-linea's strategy to extend the commercial footprint across Europe for ASTar, France is the 6th European country with commercial coverage, either through a distribution partnership or direct Q-linea presence.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	EUROBIO SCIENTIFIC	14.28 EUR	-1.11%	-4.16%	156M
	Q-LINEA AB	3.295 SEK	+64.91%	+59.56%	35.11M

Latest news about Q-linea AB

Q-linea AB Presents Strong ASTar Results At AMCLI	Mar. 13	CI
Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Q-linea Presents at AMCLI	Feb. 15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	Feb. 09	MT
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	Feb. 01	CI
Q-linea Lands First ASTar Order from Finnish Distributor	Jan. 31	MT
Q-Linea AB Receives an Order for an ASTar System	Jan. 31	CI
Q-linea to Cut 40 Jobs in Cost Savings Program	Jan. 30	MT
Q-linea AB Announces CEO Changes	Jan. 22	CI
Q-linea AB Expands the Gram-Negative Panel	Jan. 17	CI
Q-Linea Wins Public Tender for Rapid AST	Jan. 15	CI
Q-linea Installs First ASTar Systems in US; Shares Jump	Dec. 28	MT
Q-linea Signs Distribution Deal for Benelux Region with Biomedical Diagnostics	Nov. 17	MT
Transcript : Q-linea AB, Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Q-linea AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Sweden's Q-linea Partners with Labema to Boost Presence in Finland, Baltic States	23-10-19	MT
Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy	23-10-19	CI
Q-linea AB Receives Second ASTar Order in France	23-09-28	CI
Q-linea CEO Plans Retirement in 2024; Stock Tumbles 13%	23-09-07	MT
Q-Linea AB Announces Jonas Jarvius to Step Down as CEO Before Summer 2024	23-09-07	CI
Q-Linea AB Appoints Jonas Jarvius as A New Board Member in 2024	23-09-07	CI
Q-linea Shares Gain Amid Progress of French Distribution Deal	23-07-27	MT
Q-linea AB Receives First ASTar Order in France	23-07-27	CI

Chart Q-linea AB

Duration

Period

More charts

Company Profile

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-03 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Q-linea AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
Q-LINEA AB	-10.95%	35.11M
SARTORIUS AG	-12.91%	19.08B
QUIDELORTHO CORPORATION	-46.21%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.15%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.12%	1.61B
BIOTAGE AB	+23.78%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.69%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.89%	905M
REVENIO GROUP OYJ	-7.14%	716M
VAREX IMAGING CORPORATION	-18.10%	682M

Medical Diagnostic & Testing Equipment